Welcome to Novo Nordisk Biotech Fund

Novo Nordisk Biotech Fund is the business unit within Novo Nordisk A/S responsible for the company's venture capital activities.
Novo Nordisk Biotech Fund offers equity investments into promising young companies in the health science industry.

Novo Nordisk Biotech Fund is the Corporate Venture Capital Fund of Novo Nordisk A/S

Latest news

Pieris AG enters into Anticalin collaboration with Allergan, Inc.

Affimed Therapeutics AG receives FDA Orphan Drug Designation for AFM13 against Hodgkin lymphoma